Sign in Subscribe
COVID-19

COVID-19 Research Reveals Insights into Human T Cell Memory

Strategic Insights

— 1 min read

Research conducted at Ashoka University in India has yielded significant findings on human T cell memory, particularly in regards to COVID-19. According to a new study, the expression of CD45 isoforms on human yellow fever virus vaccine (YFV-17D) specific CD8 T cells has been longitudinally examined. The study found that effector CD8 T cells at day 14 express CD45RO but switch to CD45RA positive within 4 to 6 weeks and remain CD45RA for 10 years.

Key Takeaways:

  • The study, led by researchers at Ashoka University, has revealed that human T cell memory undergoes a CD45RA to RO to RA transition in response to antigen and without antigen.
  • The research has provided evidence that this switch is regulated by antigen, and CD45RO cells transition to CD45RA in the absence of antigen.
  • In the case of SARS-CoV-2 spike-specific CD8 T cells, the study found that they can repeatedly undergo the CD45RA to RO to RA transition in vivo after SARS-CoV-2 mRNA vaccination.
  • The research suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-specific CD8 T cells rarely acquire the canonical Tcm phenotype (CD45RO+ CCR7+).
  • The study also found that human cytomegalovirus (CMV)-specific CD8 T cells transition to CD45RA in the absence of antigen and CD45RA cells become CD45RO when stimulated with CMV peptide.
  • The research has significant implications for T cell nomenclature and warrants a reevaluation of how human memory CD8 T cells are defined.

Statistics:

  • 10 years: duration for which CD45RA positive CD8 T cells remain after switching from CD45RO.
  • 4 weeks: timeframe for CD45RO cells to switch to CD45RA positivity.
  • 6 weeks: timeframe for CD45RA cells to become established.
  • 14 days: duration for which effector CD8 T cells express CD45RO.

Sources:

  • "Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature." Proceedings of the National Academy of Sciences, 2025;122(32).
  • NewsRx, 2025 AUG 24. Research Turns Spotlight on COVID-19 (Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature).
  • NewsRx, 2025 AUG 24. Researchers at Ashoka University Target COVID-19 (Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature).

Read more